Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B
详细信息    查看全文
文摘
| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Aims

To detect HBV rtM204V/I lamivudine-resistant strains in serum of patients with acute hepatitis B and to assess their biological and clinical significance.

Methods

Eighty HBV DNA-positive patients with symptomatic acute hepatitis B observed from 1999 to 2010 were enrolled. A plasma sample obtained at the first observation was tested for HBV mutants in the polymerase region by direct sequencing; the antiviral drug-resistant rtM204V/I mutations, the most frequent HBV mutants in Italy, were also sought by the more sensitive allele-specific polymerase chain reaction (PCR).

Results

No HBV mutation associated with resistance to nucleos(t)ide analogues was identified by direct sequencing, whereas allele-specific PCR identified HBV strains carrying the substitution rtM204V/I in 11 (13.7 % ) patients. Compared with those with the HBV wild strain, patients with rtM204V/I more frequently showed severe acute hepatitis B (36.4 % vs 8.7 % ; p?<?0.05) and lower values of serum HBV DNA (1.77?¡Á?106?¡À?4.76?¡Á?106 vs. 1.68?¡Á?108?¡À?5.46?¡Á?108). In addition, a multivariate analysis identified the presence of a pre-existing HCV chronic infection as independently associated with severe acute hepatitis B (p?<?0.05).

Conclusions

HBV rtM204V/I lamivudine-resistant strains were detected in serum of 11 (13.7 % ) patients with acute hepatitis B by allele-specific polymerase chain reaction. The frequent association of rtM204V/I with a more severe acute hepatitis B and with a lower viral load may?suggest that greater and/or more prolonged immune pressure might have induced their selection.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700